tiprankstipranks
Advertisement
Advertisement

AU:ENP Stock Latest News

Entropy Neurodynamics Files New U.S. Patent to Bolster IBS Psychedelic Therapy Program
Company AnnouncementsEntropy Neurodynamics Files New U.S. Patent to Bolster IBS Psychedelic Therapy Program
19h ago
ENP
Entropy Neurodynamics posts breakthrough 75% response in treatment-resistant IBS trial
PremiumCompany Announcements
Entropy Neurodynamics posts breakthrough 75% response in treatment-resistant IBS trial
2d ago
ENP
Entropy Neurodynamics Advances Psilocin Platform With BED Trial Progress and New Patent
PremiumCompany Announcements
Entropy Neurodynamics Advances Psilocin Platform With BED Trial Progress and New Patent
8d ago
ENP
Entropy Neurodynamics Director Lifts Stake via $100,000 Share Placement
PremiumCompany Announcements
Entropy Neurodynamics Director Lifts Stake via $100,000 Share Placement
16d ago
ENP
Entropy Neurodynamics Issues Shares to Directors in Lieu of Cash Fees
PremiumCompany Announcements
Entropy Neurodynamics Issues Shares to Directors in Lieu of Cash Fees
18d ago
ENP
Entropy Neurodynamics Issues New Shares in Lieu of Directors’ Fees
PremiumCompany AnnouncementsEntropy Neurodynamics Issues New Shares in Lieu of Directors’ Fees
18d ago
ENP
Entropy Neurodynamics Clears Secondary Trading for New Share Issue
Premium
Company Announcements
Entropy Neurodynamics Clears Secondary Trading for New Share Issue
22d ago
ENP
Entropy Neurodynamics Seeks ASX Quotation for 13.8 Million New Shares
Premium
Company Announcements
Entropy Neurodynamics Seeks ASX Quotation for 13.8 Million New Shares
22d ago
ENP
Entropy Advances TRP-8803 Psilocin Trial in Binge Eating Disorder
PremiumCompany Announcements
Entropy Advances TRP-8803 Psilocin Trial in Binge Eating Disorder
22d ago
ENP
Entropy Neurodynamics Issues 20 Million Unquoted Options Expiring 2029
PremiumCompany Announcements
Entropy Neurodynamics Issues 20 Million Unquoted Options Expiring 2029
1M ago
ENP
Entropy Neurodynamics Wins Shareholder Backing for Psychedelic Therapy Push
PremiumCompany Announcements
Entropy Neurodynamics Wins Shareholder Backing for Psychedelic Therapy Push
2M ago
ENP
Entropy Neurodynamics Seeks ASX Quotation for 600,000 New Shares
PremiumCompany Announcements
Entropy Neurodynamics Seeks ASX Quotation for 600,000 New Shares
2M ago
ENP
Tryptamine-Linked Entropy Neurodynamics Director Increases Equity Stake via Off-Market Transfer
PremiumCompany AnnouncementsTryptamine-Linked Entropy Neurodynamics Director Increases Equity Stake via Off-Market Transfer
2M ago
ENP
Entropy Neurodynamics Seeks ASX Quotation for 1.2 Million New Shares
Premium
Company Announcements
Entropy Neurodynamics Seeks ASX Quotation for 1.2 Million New Shares
2M ago
ENP
Entropy Neurodynamics Fully Enrols First Cohort in IV Psilocin Binge Eating Trial
Premium
Company Announcements
Entropy Neurodynamics Fully Enrols First Cohort in IV Psilocin Binge Eating Trial
2M ago
ENP
Entropy Neurodynamics Seeks ASX Quotation for 1.5 Million New Shares
PremiumCompany Announcements
Entropy Neurodynamics Seeks ASX Quotation for 1.5 Million New Shares
2M ago
ENP
Entropy Neurodynamics Narrows Half-Year Loss and Lifts Asset Backing After Rebrand
PremiumCompany Announcements
Entropy Neurodynamics Narrows Half-Year Loss and Lifts Asset Backing After Rebrand
2M ago
ENP
Entropy Neurodynamics Issues 2026 EGM Materials and Streamlines Investor Communications
PremiumCompany Announcements
Entropy Neurodynamics Issues 2026 EGM Materials and Streamlines Investor Communications
3M ago
ENP
Entropy Neurodynamics Director Increases Stake With On-Market Share Purchase
PremiumCompany Announcements
Entropy Neurodynamics Director Increases Stake With On-Market Share Purchase
3M ago
ENP
Tryptamine Therapeutics director ups stake with on-market share buy
PremiumCompany AnnouncementsTryptamine Therapeutics director ups stake with on-market share buy
3M ago
ENP
Entropy Neurodynamics Hits Milestone in World-First IV Psilocin Trial for Binge Eating Disorder
Premium
Company Announcements
Entropy Neurodynamics Hits Milestone in World-First IV Psilocin Trial for Binge Eating Disorder
3M ago
ENP
Entropy Neurodynamics Reports Encouraging First-Patient Data for IV Psilocin in Binge Eating Disorder Trial
Premium
Company Announcements
Entropy Neurodynamics Reports Encouraging First-Patient Data for IV Psilocin in Binge Eating Disorder Trial
3M ago
ENP

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >